Novo Nordisk A/S (NVO): 'How Could They Be So Far Behind?,' Wonders Jim Cramer
Novo Nordisk A/S (NYSE:NVO) is one of the .
Novo Nordisk A/S (NYSE:NVO) is a Danish pharmaceutical giant that is a key player in the weight loss drug market. The firm's shares have lost 15.7% year-to-date. Novo Nordisk A/S (NYSE:NVO) has struggled primarily due to investor fears about Eli Lilly overtaking the firm in the weight loss drug market. Other news, such as a surprise departure of the firm's CEO hasn't helped the stock pare back its losses either. Novo Nordisk A/S (NYSE:NVO)'s stock lost 6% in March after its CagriSema weight loss drug fell short of the firm's estimates. While it had expected the drug to help users lose 25% of their body weight, the trials led to a 15.7% weight reduction. Cramer commented on activist investor Parvus taking a stake in the company:
[On activist fund Parvus building a stake in the company] How could they be so far behind? You know they were first, they were first mover. And then Lilly came along, Lilly by the way, still a great stock. But maybe this is going to shake up Novo.
In his previous comments about Novo Nordisk A/S (NYSE:NVO), Cramer commented on the firm in the context of Eli Lilly:
An elderly couple receiving insulin from a pharmacist, representing healthcare company's successful pharmaceutical products.
'Okay, Eli Lilly. We bought some just the other day for the Charitable Trust. Why did we do that? Because it's down very big and yet it's been beating Novo Nordisk over and over and over again. So I just think this is a decent level to start a position if you don't have any.'
While we acknowledge the potential of NVO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
22 minutes ago
- CBS News
Senate holds marathon vote series on Trump's "big, beautiful bill" as GOP eyes July 4 deadline
Washington — A marathon vote series is underway in the Senate after the chamber debated President Trump's massive tax bill into the wee hours of the morning as Republicans work to pass the centerpiece legislation of Mr. Trump's second-term agenda. The House narrowly passed the bill last month, and Senate Republicans have been working to put their mark on the legislation, treading carefully so as not to throw off the delicate balance in the lower chamber. The House will need to approve the Senate's changes to the bill before it can head to the president's desk for his signature. And lawmakers are trying to move quickly, with a self-imposed July 4 deadline to get the measure signed. The Senate worked through the weekend as the GOP nears a final sprint on the legislation ahead of the deadline. Titled "One Big, Beautiful Bill," the legislation includes increased spending for border security, defense and energy production, which is offset in part by cuts to healthcare and nutrition programs. The Congressional Budget Office estimated Sunday that the legislation would increase the deficit by nearly $3.3 trillion over the next decade. Senate Republicans advanced the legislation late Saturday, with all but two voting in favor following hours of delay as the GOP worked to iron out last-minute details and dispel concern among holdouts. The vote on the motion to proceed stayed open for more than three hours as holdouts sought assurances from GOP leaders. Some tweaks were made to the bill before Republicans ultimately received enough votes to move forward. Senate Majority Leader John Thune (R-SD) walks in Capitol Hill, as Republican lawmakers struggle to pass President Donald Trump's sweeping spending and tax bill, in Washington, D.C., June 30, 2025. Elizabeth Frantz / REUTERS Senate Democrats further delayed the legislation's path forward by forcing the bill to be read in its entirety, starting late Saturday. After nearly 16 hours, the Senate clerks concluded their reading of the bill on the floor, starting the clock on debate. Each side then had up to 10 hours for debate. The "vote-a-rama" Following debate, and a break until the morning, the Senate began what's known as a "vote-a-rama" Monday in which senators may offer an unlimited number of amendments and force the chamber to cast vote after vote. Democrats have been using the opportunity to put their GOP colleagues on the record on a number of controversial issues ahead of the midterm elections. But before the chamber could get to the amendment votes, senators had to address an outstanding disagreement over the current policy baseline, an accounting approach that would make it appear that extending the current tax policy would cost nothing. Senate Majority Leader John Thune maneuvered Sunday to allow the use of the current policy baseline, before Senate Minority Leader Chuck Schumer quickly appealed the move, requesting a vote as Democrats railed against it as the "nuclear option." The chamber voted 53-47, along party lines, to affirm the use of the current policy baseline on Monday. Schumer said that Democrats would bring "one amendment after the other" Monday, and began the process by offering an amendment to send the bill back to the Finance Committee to revisit some of its health care provisions. The chamber voted down the amendment in a party-line vote. Democrats proposed a number of amendments to attempt to roll back some of the bill's more controversial provisions. Sen. Ed Markey, a Massachusetts Democrat, proposed an amendment to remove the bill's provisions that he said would force rural hospitals to limit their services or close their doors. And Sen. Chris Coons, a Delaware Democrat, proposed an amendment to eliminate what he called "red tape" around Medicaid eligibility. Other amendments proposed by Democrats concerned cuts to food assistance and state provider taxes, among a number of related issues. The amendments fell short. GOP Sen. John Cornyn of Texas offered the first Republican-led amendment, which would have reduced federal Medicaid expansion payments to states that provide coverage to undocumented immigrants charged with specific crimes. The Senate's rulemaker, known as the parliamentarian, determined that the provision would require a 60-vote threshold. The amendment fell short, though it picked up support from a handful of Democrats. Amid the slew of votes, anticipation swirled around a consequential amendment expected to be put forward by GOP Sen. Rick Scott of Florida later Monday. The amendment would significantly reduce the federal Medicaid expansion match made under the Affordable Care Act, barring new enrollees after 2030, in a move that would make the bill more palatable to some fiscal hawks. Thune has backed the amendment, calling it "great policy," and forecasted that it will get significant support among the Senate GOP. But whether it has enough support to be added to the bill remains to be seen. The chamber's pace began to slow Monday evening. As the amendment votes dragged on, Democrats accused Republicans of stalling. "They're delaying, they're stalling, they're cutting a lot of back-room deals," Schumer told reporters. "But we're just pushing forward, amendment after amendment — they don't like these amendments." Asked by reporters about the holdup Monday night, Thune said, "we're just kind of figuring out what everybody has to have in terms of votes." He added that Senate GOP leaders are working to construct a list, and expressed confidence that the chamber could still vote on final passage overnight. The path to passage Senate Republicans have been pursuing the legislation through the budget reconciliation process, which enables the party in the majority to move ahead without support from across the aisle. With only a simple majority required to advance the measure, rather than the 60-votes needed to move forward with most legislation, Senate Democrats have few mechanisms to combat the bill's progress. With a 53-seat majority, Senate GOP leaders can only afford to lose support from three Republicans — and would then still require a tie-breaking vote from Vice President JD Vance. And although a number of senators who had expressed opposition to the measure ultimately decided to advance it Saturday, how they will vote on the measure in a final form remains unclear. Sens. Rand Paul of Kentucky and Thom Tillis of North Carolina were the two Republicans to oppose the bill's advancement Saturday, and are expected to oppose the legislation on final passage. Tillis, who announced Sunday that he is not seeking reelection, took to the Senate floor that night to outline his opposition to some of the bill's cuts to Medicaid, claiming "Republicans are about to make a mistake on health care" and arguing that the GOP is "betraying our promise." "It is inescapable that this bill in its current form will betray the very promise that Donald J. Trump made" to target only waste, fraud and abuse in the entitlement program, Tillis said, claiming that the president has been "misinformed" The North Carolina Republican argued that the July 4 deadline is an "artificial" one, saying Senate Republicans are rushing, while encouraging the chamber to "take the time to get this right" and align more closely with the House's Medicaid provisions. But Senate GOP leaders are still moving ahead. Thune, a South Dakota Republican, delivered a defense of the bill on the Senate floor ahead of the vote-a-rama Monday, pushing back on criticism over Medicaid cuts, the impact on the deficit and the use of the current policy baseline. "Let's vote," Thune said. "This is good for America." When asked whether he's confident Senate Republicans have the votes to pass the legislation, the majority leader told reporters, "Never, until we vote." Vance was on hand to break a possible tie vote Saturday, though his vote ultimately wasn't needed. Still, the vice president met with GOP holdouts in the majority leader's office Saturday as the White House put pressure on lawmakers to get the bill across the finish line. White House press secretary Karoline Leavitt said Monday that the president has "been in touch with lawmakers all weekend long to get this bill passed." "The White House and the president are adamant that this bill is passed and that this bill makes its way to his desk," Leavitt said. "Republicans need to stay tough and unified during the home stretch, and we are counting on them to get the job done." Meanwhile, Sen. Mark Warner, a Virginia Democrat, warned Sunday that the legislation would be a "political albatross" for Republicans, while suggesting that the bill could even lose support among the GOP, saying "it's not over until it's over." "I think many of my Republican friends know they're walking the plank on this, and we'll see if those who've expressed quiet consternation will actually have the courage of their conviction," Warner said Sunday on "Face the Nation with Margaret Brennan." and contributed to this report.
Yahoo
26 minutes ago
- Yahoo
As stocks notch records, sentiment lags behind, but 'Fed put' to support bulls
-- Stocks are reaching for the skies, clinching fresh records even as a key gauge of investor sentiment lags behind, with recession worries still simmering beneath the surface. But Yarndeni Research says the bull run is far from over, as the 'Fed put' is back in play and should cushion any fallout from tariff-driven hits to growth. 'Despite the latest record highs for the S&P 500 and Nasdaq, the Investor Intelligence and AAII Bull-Bear Ratios remain relatively low… This suggests that stock investors remain wary. It's as though they're chanting Roseannadanna's mantra: '[I]t's always something—if it's not one thing, it's another,'' Yarndeni Research said in a recent note. Investors have found fresh relief as the Israel-Iran conflict cooled and optimism builds for a resolution to Trump's trade war, even as talks with Canada hit a snag. Offsetting that setback, the U.S. and China resolved a rare earths dispute, and new trade agreements are reportedly in the pipeline. The S&P 500 and Nasdaq both closed at record highs on Friday, with the S&P 500 up 5% year-to-date. Yet, under the surface, sentiment remains cautious. The Investor Intelligence and AAII Bull-Bear Ratios are still subdued, reflecting persistent recession fears and a string of weaker-than-expected economic indicators. The Citigroup (NYSE:C) Economic Surprise Index has stayed in negative territory, and Q1 GDP was revised down to -0.5%. Personal income and spending both dipped in May, while unemployment claims remain low but continuing claims are creeping higher—a sign it's taking longer for the jobless to find work. Still, Yarndeni's take is that these are signs of a 'soft patch,' not a full-blown slowdown. Four of the five best-performing S&P 500 sectors so far this year are cyclical—Industrials, Communication Services, Financials, and Information Technology—underscoring long-term optimism around tech capex, onshoring, and capital markets. The report expects consumer spending to rebound as stock prices hit new highs and tariff turmoil moderates. Yarndeni argues, however, that the 'Fed put' is back: if the economy stumbles, the Federal Reserve is likely to cut rates twice before year-end. Even if the base case is for resilience without Fed help, the futures market is already pricing in two cuts over the next six months and four in the next year. That safety net, Yarndeni says, should keep the bull market intact—even if growth wobbles. Related articles As stocks notch records, sentiment lags behind, but 'Fed put' to support bulls Circle applies for U.S. trust bank license after successful IPO Elon Musk criticizes spending bill, calls for new political party Sign in to access your portfolio
Yahoo
26 minutes ago
- Yahoo
Bitcoin Carried Crypto Markets in 2025's First Half as Altcoins Crumbled. What's Next?
On the surface, the crypto market barely moved in the first half of 2025. Despite all the tantrum about tariffs, impending recession, war, and heightened expectations of crypto friendly policies and a digital asset strategic reserve with Donald Trump's return to the White House, the total market capitalization of cryptocurrencies, measured by TradingView, inched up a measly 3% to $3.27 trillion over the past six months. Looking closer, the performance was starkly uneven, with bitcoin BTC holding up the rest of the market. BTC climbed 13% in the first six months of 2025, continuing to outshine the broader market. Meanwhile, Ethereum's ether ETH, the second-largest crypto asset, tumbled 25%, and Solana SOL shed nearly 17%. Smaller and riskier tokens endured even sharper losses: the OTHERS index on TradingView, which excludes the 10 largest assets by market cap, plunged 30%. Despite the modest start to the year, some analysts see room for renewed upside. Joel Kruger, market strategist at LMAX Group, noted that July has historically been a strong month for crypto, averaging 7.56% returns since 2013. 'We enter a period that has traditionally delivered stronger returns,' said Kruger. 'With the second half of the year historically producing outsized gains, the broader setup remains encouraging.' Kruger also highlighted that the crypto treasury strategy trend is increasingly expanding beyond bitcoin, with firms announcing plans to accumulate digital assets like ETH. Coinbase analysts also maintained a positive outlook for crypto through the second half of the year, driven by favorable macroeconomic backdrop, potential rate cuts by the Federal Reserve and increasing regulatory clarity in the U.S. with lawmakers advancing legislation for stablecoins and the broader crypto market structure. Still, the next couple months could be lackluster, Bitfinex analysts warned. The next quarter-year starting with July has been historically the weakest for bitcoin, averaging only 6% gains since 2013, they said in a Monday report. "This is also where average volatility is subdued, adding to our bias of range bound price action continuing for longer," the authors noted. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
